ArticleBMC pharmacology & toxicology2025

Melasma secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS).

Yaxin Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.